Date : 6/23/2022 5:39:58 AM
From : "Trialect"
To : shimonz@nrcn.gov.il
Subject : Matsumae Short-Term Research Fellowship in Japan on Trialect​: Deadlines Fast Approaching

Matsumae Short-Term Research Fellowship in Japan on Trialect​: Deadlines Fast Approaching
 
Trialect
 
 
Dear Dr. shimonz@nrcn.gov.il

We have a posting soliciting applications for the Masumae Short-Term Research Fellowship in Japan on Trialect. Twenty Applications are accepted from throughout the world. Applicants should not have past or current experiences of staying in Japan (other than short-term stays such as for sightseeing or conferences). A monthly allowance is provided to cover expenses for research activities (including materials) and living expenses in Japan in addition to economy class airfare. The fellowship period is for three to six months between April 2023 to March 2024. Click here to know more: Matsumae Fellowship.
 
Thanks,
Sandra Miller
Trialect Support,
support@trialect.com
+1.805.852.1402 (7 AM-11 AM EST)
 
Science&minds Platform: Trialect will soon launch the https://scienceandminds.com/ platform that matches CLIENTS with EXPERTS to facilitate short-term projects in healthcare and biomedical sciences. For example, a client (pharma, academic scientist, physicians) can post projects requesting help with writing a grant, case report, or a conference abstract, protocols, help with biostatistics, or opinion about an R&D program on a particular disease, and an EXPERT can negotiate a price and execute the project. I'll explain to you in our 1-minute video on Youtube at https://www.youtube.com/watch?v=6-JuxmBW7-4.
 
 Follow Us on:           
 
 


Disclaimer: You are receiving this email based on your expertise and past work as determined by the sponsors or by our scientific affairs. Trialect Inc is a United States Incorporation that posts grants, fellowships, courses, industry-academia partnerships to professionals in the healthcare and life sciences industry. We are in no way affiliated with, endorsed, or supported by the sponsors.
© 2022 Trialect
 
If you wish to unsubscribe from our newsletter, click here